Results 161 to 170 of about 52,849 (269)

Monetary policy reaction function: A Bayesian analysis for the BRICS. [PDF]

PLoS One
Waheed F, Rashid A, Basit A, Maroof L.
europepmc   +1 more source

High-frequency identification of monetary policy shocks in Japan. [PDF]

Jpn Econ Rev (Oxf), 2022
Kubota H, Shintani M.
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Financial stability in sub-Saharan Africa: Does monetary policy matter? [PDF]

Heliyon
Zanfack LT, Ngounou BA, Noubissi Domguia E, Possi Tebeng EX.   +3 more
europepmc   +1 more source

COVID-19 and Exchange Rates: Spillover Effects of U.S. Monetary Policy. [PDF]

Atl Econ J, 2022
Yilmazkuday H.
europepmc   +1 more source

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

Relationship between financial inclusion, monetary policy and financial stability: An analysis in high financial development and low financial development countries. [PDF]

Heliyon, 2023
Oanh TTK, Van LTT, Dinh LQ.
europepmc   +1 more source

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

British Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić, Ivana Stević, Elvira Meni Maria Gkrinia, Dinko Vitezić, Slobodan Janković   +4 more
wiley   +1 more source

External financial and monetary policy shocks: Do they matter for Korean macroeconomy? [PDF]

Heliyon
He Y.
europepmc   +1 more source